BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 177 filers reported holding BLUEBIRD BIO INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,000 | -33.3% | 541 | +1.7% | 0.00% | – |
Q1 2022 | $3,000 | -80.0% | 532 | -63.9% | 0.00% | -100.0% |
Q4 2021 | $15,000 | -50.0% | 1,475 | -6.9% | 0.00% | 0.0% |
Q3 2021 | $30,000 | -42.3% | 1,585 | -3.3% | 0.00% | -50.0% |
Q2 2021 | $52,000 | +6.1% | 1,639 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $49,000 | -31.9% | 1,639 | -1.9% | 0.00% | -50.0% |
Q4 2020 | $72,000 | -21.7% | 1,671 | -2.3% | 0.00% | -33.3% |
Q3 2020 | $92,000 | -11.5% | 1,711 | +0.4% | 0.01% | -25.0% |
Q2 2020 | $104,000 | +28.4% | 1,705 | -3.1% | 0.01% | +14.3% |
Q1 2020 | $81,000 | -79.2% | 1,760 | -60.3% | 0.01% | -74.1% |
Q4 2019 | $389,000 | – | 4,434 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |